Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJNX2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,245
Award facts
- Contract value 100% obligated
- $10,245.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,245.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYMLOS 80 MCG Dose Pen Injector (1.56ML). This delivery order, issued without set-aside designation, is expected to be completed by December 15, 2025, and represents a single-award transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's participation in the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's prime vendor contract, valued at $499,999,999 and extending through December 31, 2036, authorizes the company to supply a full range of pharmaceuticals including branded and generic prescription drugs, biologics, and medical consumables. The company's established performance across numerous delivery orders demonstrates its capability to support the specialized pharmaceutical requirements of the federal military medical system on a global basis.
Quick answers
Who was awarded contract SPE2DR26FJNX2?
SPE2DR26FJNX2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FJNX2 worth?
The government has obligated $10,245 on SPE2DR26FJNX2.
Is contract SPE2DR26FJNX2 an order under another contract?
Yes. SPE2DR26FJNX2 is a delivery order under SPE2DR25D9226, an indefinite delivery contract.
Was contract SPE2DR26FJNX2 competed?
The extent of competition for SPE2DR26FJNX2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award